Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1921 1
1924 4
1925 7
1926 3
1927 1
1931 1
1941 1
1942 1
1946 6
1947 2
1948 6
1949 1
1950 6
1951 3
1952 1
1953 3
1954 3
1955 1
1956 5
1957 5
1958 3
1959 1
1960 2
1961 3
1962 2
1963 2
1964 8
1965 4
1966 2
1967 3
1968 6
1969 1
1970 2
1971 3
1972 4
1973 4
1974 5
1975 8
1976 3
1977 1
1978 1
1980 1
1981 2
1983 2
1984 3
1985 4
1986 4
1987 2
1989 2
1990 2
1992 2
1993 2
1994 3
1995 4
1996 2
1997 2
1998 1
1999 1
2000 2
2001 2
2002 3
2003 2
2005 2
2006 2
2008 8
2009 17
2010 6
2011 7
2012 11
2013 9
2014 8
2015 9
2016 9
2017 12
2018 7
2019 8
2020 13
2021 17
2022 17
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

333 results

Results by year

Filters applied: . Clear all
Page 1
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.
Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. Stary HC, et al. Among authors: chandler ab. Circulation. 1995 Sep 1;92(5):1355-74. doi: 10.1161/01.cir.92.5.1355. Circulation. 1995. PMID: 7648691 Review.
Nutrient Timing: A Garage Door of Opportunity?
Arent SM, Cintineo HP, McFadden BA, Chandler AJ, Arent MA. Arent SM, et al. Among authors: chandler aj. Nutrients. 2020 Jun 30;12(7):1948. doi: 10.3390/nu12071948. Nutrients. 2020. PMID: 32629950 Free PMC article. Review.
The global assessment of OCD.
Pampaloni I, Marriott S, Pessina E, Fisher C, Govender A, Mohamed H, Chandler A, Tyagi H, Morris L, Pallanti S. Pampaloni I, et al. Among authors: chandler a. Compr Psychiatry. 2022 Oct;118:152342. doi: 10.1016/j.comppsych.2022.152342. Epub 2022 Aug 6. Compr Psychiatry. 2022. PMID: 36007341 Free article. Review.
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AG, Hasselblad V, Ortel TL; BRIDGE Investigators. Douketis JD, et al. N Engl J Med. 2015 Aug 27;373(9):823-33. doi: 10.1056/NEJMoa1501035. Epub 2015 Jun 22. N Engl J Med. 2015. PMID: 26095867 Free PMC article. Clinical Trial.
Response.
Tinsley GM, Chandler AJ, Arent SM. Tinsley GM, et al. Among authors: chandler aj. Med Sci Sports Exerc. 2022 Jan 1;54(1):190. doi: 10.1249/MSS.0000000000002780. Med Sci Sports Exerc. 2022. PMID: 34907137 No abstract available.
Parents and substance use.
Radcliffe P, Chandler A, Martin F, Whittaker A. Radcliffe P, et al. Among authors: chandler a. Int J Drug Policy. 2019 Jun;68:97-100. doi: 10.1016/j.drugpo.2019.02.011. Epub 2019 Apr 6. Int J Drug Policy. 2019. PMID: 30962037 No abstract available.
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Piña IL; HF-ACTION Investigators. O'Connor CM, et al. JAMA. 2009 Apr 8;301(14):1439-50. doi: 10.1001/jama.2009.454. JAMA. 2009. PMID: 19351941 Free PMC article. Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, Rajasekhar VK, Yoshida A, Kondo H, Hata T, Tazawa H, Dogan Y, Moore MAS, Fujiwara T, Ozaki T, Purdue E, Healey JH. Fujiwara T, et al. Among authors: chandler a. Mol Cancer Ther. 2021 Aug;20(8):1388-1399. doi: 10.1158/1535-7163.MCT-20-0591. Epub 2021 Jun 4. Mol Cancer Ther. 2021. PMID: 34088832 Free PMC article.
333 results